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MANDATORY HIV TESTING ISSUES IN STATE NEWBORN

SCREENING PROGRAMS
JOHN M. NABER, 1
DAVID R. JOHNSON, 2

ABSTRACT
On May 23, 1991, an editorial by Dr. Marcia Angell, the executive editor of
the New England Journal of Medicine, recommended that all newborns, health
care workers, pregnant women and hospital patients be tested for human
immunodeficiency virus (HIV) infection. 3 Dr. Angell noted that HIV infection
in newborns is more common than phenylketonuria (PKU) which is routinely
tested in all newboms. 4 This idea was rejected by Dr. June Osborn, chair of the
National Commission on AIDS and Dean of the University of Michigan's
School of Public Health. Dr. Osborn prefers voluntary testing with informed
consent and counseling 5 and stated "'[tihere's nothing routine about an HIV
test.' 6 Newborn screening programs for serious but treatable diseases have
achieved success and wide acceptance over the past thirty years. Development
of these programs involved a struggle with legal and social policy issues as
well as scientific and medical issues. 7 The possibility of establishing the
nation's first newborn screening program for HIV occurred when the Michigan
House of Representatives, in July of 1992, passed a Bill mandating
non-anonymous HIV testing of newborns. Although it did not pass into law in
1992, a substantially similar bill has been introduced for 1993. Considering
issues of informed consent, confidentiality, possible newborn screening
refusals, and the potential for identifying HIV-exposed neonates through
prenatal testing, the addition of non-anonymous HIV testing to routine
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newborn screening appears to be neither efficient nor ethically defensible. This
position is reviewed 'for states that may be considering the use of newborn
screening to detect HV infection.
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I. INTRODUCTION TO NEWBORN (GENETIC) SCREENING
Currently, at least five major types of genetic screening programs have
developed in the United States including: "1)disease detection in newborns;
2) carrier (heterozygote) detection; 3) prenatal disease detection; 4) genetic
screening in the workplace; and 5) forensic testing of alleged or proven
criminals [through DNA analysis]."8 The National Academy of Sciences (NAS)
recommends genetic screening only when carried out under controlled
conditions and "[tihere is evidence of substantial public benefit and acceptance,
including acceptance by medical practitioners.' 9
Disease detection in newborns is perhaps the largest and most successful
screening program of the five. It became popular in the United States in the
mid-1960's, when many states began universal screening of newborns for
phenylketonuria (PKU). PKU is a severe genetic disease caused by an absence
or alteration of the gene that produces phenylalanine hydroxylase.10 This

8

1d. at 476.

9

Committee for the Study of Inborn Errors of Metabolism, Genetic Screening:

Progranis,Principles,and Research, NATIONAL ACADEMY OF SCIENCES 1 (1975) [hereinafter
GENETIC SCREENING].
10
Ara Y. Tourian & J.B. Sidney, Phenylketonuria,THE METABOLIC BASIS OF INHERITED
DISEASE 241-42 John B. Stanbury, et al. eds., 4th ed. 1978). Phenylalanine hydroxylase
is an enzyme involved in the metabolism of phenylalanine, "an essential amino acid for
protein synthesis." Id. at 240 (citations omitted).
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disease is easily treated with a diet low in phenylalanine. If untreated, PKU
leads to irreparable and unnecessary mental retardation.
The newborn screening model is fairly straightforward. Typically, before the
infant is discharged from the hospital (around 24 to 36 hours of age), heel stick
blood is placed on special filter paper, dried, and mailed to the state health
department for testing. Medical and laboratory research has led to the
discovery that other diseases could also be screened in newborns using these
dried blood specimens. Currently, all states and the District of Columbia test
all newborns for at least PKU and congenital hypothyroidism."1
There are generally five criteria to satisfy before a disease is considered
appropriate for newborn screening:
1. The disease must be well defined and serious enough to justify
mass screening;
2. There must be an accurate testing method available;
3. The cost of the test must be reasonable;
4. There must be available treatment for the disorder; and
to refer
5. There must be adequate medical management facilities
12
infants for confirmatory diagnosis and treatment.
Although newborn screening is often classified as genetic screening, these
criteria do not require that the screened disorder have a genetic origin. In fact,
congenital hypothyroidism, which is part of every newborn screening program
in this country is usually not a genetic disease.
In Michigan, newborn screening is mandated by Mich. Comp. Laws Ann.
§ 333.5431, which states that all infants born in Michigan shall be tested "for
phenylketonuria, galactosemia, hypothyroidism, maple syrup urine disease,
biotinidase deficiency, sickle cell anemia, congenital adrenal hyperplasia, and
other treatable but otherwise handicapping conditions as designated by the
department."
Strict quality assurance guidelines in state newborn screening programs
have been developed to assure program proficiency. 13 Many of these programs
have developed with the assistance of the American Bar Foundation and the
Centers for Disease Control and Prevention (CDC). Program success is the
result of drafting of adequate laws and establishing clear guidelines. Proper

1
The Council of Regional Networks for Genetic Services (CORN), Newborn Screening
Report: 1990, Table NBS 1A (Final Rept. Feb. 1992).
12 H.S. Cuckle & N.J. Wald, Principles of Screening, ANTENATAL AND NEONATAL
SCREENING 19 (N.J. Wald ed. 1984). See also, Genetic Screening, supra note 9 at 2.
13
A detailed discussion of this topic is found in Legal Liability and Quality Assurance

in Newborn Screening, AMERICAN BAR FOUNDATION (Lori B. Andrews, ed. 1985).
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laws and guidelines require careful consideration of the many issues that
14
surround these programs.
II. MATERNAL HIV SEROPREVALENCE

STUDY BY THE CENTERS FOR
DISEASE CONTROL AND PREVENTION

Studies have shown the median time from human immunodeficiency virus
(H-WI)infection to the development of acquired immunodeficiency syndrome
(AIDS) in adults is approximately ten years. 15 Many infants with perinatally
16
acquired HIV infection, however, become symptomatic in the first year of life.
Women infected with HIV are able to transmit the infection not only to their
sex partners but also to their offspring. 17 Evidence suggests that this vertical
transmission of HIV infection to infants can occur prior to delivery
(congenital/transplacental, similar to rubella), during delivery (similar to
hepatitis B), or after delivery (through breast feeding).18 The rate of perinatal
transmission of HIV has ranged from 12.9 to 39 percent in various studies, 19
and is thought to be close to 30 percent overall. 20 In short, approximately 30
percent of HIV infected women who give birth transmit the infection to their
newborn.
In 1988, the CDC began a surveillance study to anonymously measure the
HIV infection rate of child bearing women in the United States (including
Michigan) and Puerto Rico using the dried blood collected for newborn
screening.21 Under CDC guidelines, personal identifiers from the newborn
screening cards are removed before the actual HIV test is performed. 22 Certain
14
The Michigan Department of Public Health expects the development stage of
adequate screening protocols for the disease congenital adrenal hyperplasia, which
became a mandated screen as of June 1, 1992, may take up to one year.
15

Marta Gwinn, et al., Prevalence of HIV infection in Childbearing Women in the United
States; Surveillance Using Newborn Blood Samples, 265 JAMA 1704 (1991) (citations
omitted). MV infection alone denotes presence of the causative agent for AIDS within
a person who may not have any signs/symptoms of immune deficiency. AIDS denotes
the development of signs/symptoms of immune deficiency (e.g., decreased white blood
cell counts, opportunistic infections).
16

Task Force on Pediatric AIDS, American Academy of Pediatrics, Guidelines for
Human Immunodeficiency Virus (HIV)-Infected Children and Their Foster Families, 89
PEDIATRIcS 4,681 (1992) (citations omitted) [hereinafter Guidelinesfor FosterFamilies].
17

Id.

18

Task Force on Pediatric AIDS, American Academy of Pediatrics, PerinatalHuman
Immunodeficiency Virus (HIV) Testing, 89 PEDIATRICS 4, 791 (1992) (citations omitted)
[hereinafterPerinatal HIV Testing]. The descriptive terms specified in the parentheticals
are taken directly from this source.
19

1d. (citations omitted).

20

Gwinn, supra note 15, at 1706.

21

1d. at 1704.

22

1d. at 1705.
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demographic data such as mother's age group, race, and geographic region of
residence are retained. Although a newborn's dried blood specimen is tested,
the current testing method actually measures HIV infection in the mother, not
the newborn. This is because the test measures the presence of maternal HIV
antibodies in the newborn's blood. These antibodies are produced in the
mother in response to.her HIV infection and cross through the placenta and
into the blood of the fetus. These maternal HIV antibodies can remain in the
23
newborn's blood for up to 18 months.
Currently, data for this surveillance study are being collected from newborn
24
screening programs in 44 states, Puerto Rico, and the District of Columbia.
Michigan Department of Public Health (MDPH) staff claim this study "is
particularly valuable because it provides a view of the HIV epidemic that cuts
across the broad geographical, socioeconomic, ethnic, and age spectrum of the
25
population of women giving birth in Michigan." In Michigan, 299 (0.68 per
1,000 annual births) women tested HIV positive from July, 1988, through June,
1991.26 "The majority (78 percent) are from the Detroit area and one-half are
black. The rate is fairly evenly distributed across the range of age groups. No
consistent upward or downward trend is apparent."27 The results of the entire
CDC study estimate that 6079 (1.5 per 1,000 births) HIV infected women gave
28
birth nationwide in the two year period starting in mid-1988. Assuming 30
percent transmission of the HIV to their newborns, this led to an estimated 1824
29
HIV-infected newborns.

III. RECENT ACTIVITY ON MATERNAL HIV ANTIBODY TESTING BY
NEW JERSEY AND MICHIGAN LEGISLATURES
New Jersey and Michigan are currently the only states to have introduced
legislation concerning required non-anonymous HIV testing of newborns. On
June 24, 1991, New Jersey State Senator Bassano, and other sponsors,
introduced a Bill to the New Jersey Senate Committee on Institutions, Health
and Welfare that requires HIV testing for hospital patients, health care
30
professionals working in hospitals, pregnant women and newborn infants.

23

Guidelinesfor Foster Families, supranote 16, at 681.

24

PerinatalHIV Testing, supra note 18, at 791.

25Michigan Department of Public Health, PolicyStatement on HIV Testing ofNewborns,
(Draft 1992) (on file at the Newborn Screening Office, Mich. Dep't. of Pub. Health)
[hereinafter MDPH Policy Statement].
26[d.
27

Id.

28

Gwinn, supra note 15, at 1706.

29

1d. at 1707 (Table 3).
301990 N.J. Senate Bill No. 3588 204th Legislature -- Second Regular Session (1991)
[hereinafter 1991 N.J.S. 35881.
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Sen. Bassano's office recently indicated that this Bill was not passed in 1991,
nor was it reintroduced in 1992.31
In 1991, when the New Jersey Bill was introduced, the sponsors, concerned
with the spread of AIDS, 32 reasoned that:
The testing of pregnant women and newborn infants for HIV is a
reasonable part of a rigorous epidemiological approach to the AIDS
epidemic, given the accuracy of new confirmatory tests and the fact
that perinatally transmitted HIV infection is now more common than
congenital syphilis or phenylketonuria, both of which are tested for on
a routine basis, as well as the need for HIV infected women to make
informed choices about family planning, and the public
health
33
imperative to treat infected newborns as early as possible.
An important feature of this Bill was that it also required the newborn's mother
to receive pre-test and post-test counseling and give written informed consent
prior to HIV testing of herself or her newborn. 34
In Michigan, on April 28,1992, House Bill 5863 was introduced by Rep. John
Jamian, and other sponsors, to amend the Michigan Public Health Code.
Applicable provisions of this Bill include, in part:35
Sec. 333.5133
(1) Except as otherwise provided in this section, a physician who
orders an HIV test or a health facility that performs an HIV test shall
provide counseling appropriate to the test subject both before and after
the test is administered.
(2) Except as otherwise provided in this part, a physician, or an
individual to whom the physician has delegated authority to perform
a selected act, task, or function under section 16215, shall not order an
HIV test for the purpose of diagnosing HIV infection without first
receiving the written, informed consent of the test subject...

31Telephone call to N.J. State Senator C. Louis Bassano's office (July 13, 1992).
321991 N.J.S. 3588, supra note 30:
1. The Legislature finds and declares that:
a. New Jersey currently ranks fifth among all of the states, after
New York, California, Florida and Texas, in the number of
reported AIDS cases, with a reported cumulative total of
almost 11,000 persons with AIDS, of whom more than 60%
have died.
b. The Department of Health has estimated that between 30,000 and
50,000 New Jerseyans are infected with HIV, and that by 1992, the
cumulative total of diagnosed AIDS cases in the State may be
approximately 17,500 persons.
33
1d.
34 Id. at §§ 5-6.
35 This is the 'as substituted' version and was mailed from Mich. Rep. John Jamian's
(65th District) office on July 13, 1992 [hereinafter 1992 M.H.B. 58631.
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(14) This section does not apply to an HIV test performed upon a
newborn infant under section 5431.
Sec. 333.543136
(1) A health professional in charge of the care of a newborn infant.
shall administer... a test for ... HIV or an antibody to HI ....If
the federal approval [for HIV tests] is denied or if no or insufficient
federal funds are
37available for that purpose, then the department shall
use state funds.
On June 25,1992, the House Committee on Public Health recommended Bill
5863, as substituted, 38 to the Michigan House of Representatives. Although the
Bill was passed in the House (90 in favor; two opposed) on July 22,1992, it was
not enacted into law in 1992. A substantially similar bill has been introduced
for 1993. Reading all these sections of the Bill together, HIV would be treated
like the other seven newborn screens except that it would require "in person"
notification of positive results. This Bill requires counseling and informed
consent prior to most other types of HIV testing. However, subsection 14 makes
an exception to informed consent and counseling requirements for newborn
HIV screening. The practical effect of this exception would mean that all
women who give birth in Michigan would be tested for HIV through their
infants without counseling or informed consent requirements.
IV. ANALYSIS OF MANDATORY HIV TESTING AND REPORTING IN
NEWBORN SCREENING
With few exceptions, 39 authors who have written on this topic are opposed
to mandatory newborn testing for maternal HIV antibodies. The National
Academy of Sciences' Institute of Medicine stated on January 16, 1991, that
routine HIV screening of newborns was unjustified because the tests are
inconclusive in newborns. 40 The American Academy of Pediatric's Task Force
on Pediatric AIDS expressly opposes this "mandatory (involuntary) maternal
and/or newborn testing."41 Instead, they recommend HIV testing be routinely
offered to all pregnant women and all women of childbearing age. The Academy
particularly encourages testing for those women at increased risk for HIV

36

Cf. supra notes 13-14 and accompanying text for current text of what is currently
tested under this section.
37 1992 M.H.B. 5863, supra note 35, at 12-13.
38 See Michigan Bill Tracking-State Net (LEXIS).
39 See Angell, supra note 3 and accompanying text; Ronald Bayer, Should Newborns
be Routinely Tested for HIV?, 7 MED. ETHICS 1, 10 (Feb. 1992).
40Marlene Cimons, AIDS Testingfor PregnantWomen Urged, L.A. TIMES, Jan. 16,1991,
at A19 [hereinafter AIDS Testing Urged].
41

PerinatalHIV Testing, supra note 18, at 793.
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infection because of engaging in high-risk behaviors and/or living in areas
with high HIV-seroprevalence rates.4 2
The language of Michigan House Bill 5863 would have significant effects. It
would, for the first time in Michigan and the United States, mandate
non-anonymous HIV testing of newborns, without the informed consent of the
mother.
Since newborn screening began in the mid-1960's, it has been standard
practice to carefully review each type of screen before it is mandated. This type
of review did not occur with Michigan House Bill 5863. Issues that should be
reviewed prior to initiating newborn HIV screening include: the five
guidelines for establishing a newborn screen (discussed supra); informed
consent; confidentiality in newborn screening; and newborn screening refusals.
These issues should then be balanced against the adequacy of identifying HIV
positive newborns under current laws and practices relating to prenatal HIV
testing.
A. Guidelinesfor Establishinga Newborn Screen
There are five general criteria used to determine if a disease is appropriate
for newborn screening. 43 The two most debated criteria in newborn HIV
screening are the availability of treatment and availability of an accurate testing
method.
Various treatment protocols for HIV infection have been gaining acceptance
in the medical community. The MDPH staff have stated that, "[a]lthough there
is no cure for HIV infection, there are a number of early interventions that can
prolong length and quality of life for newborns and children. These
interventions are not without controversy but they can be useful."44 Further,
the American Academy of Pediatrics recommends that as part of treatment,
"[s]ervices must be provided for the families as well as for individual
HIV-infected women and should include psychosocial, behavioral, and clinical
support."45
There remains some debate on the accuracy of the testing method and
interpretation of newborn HIV test results. The current CDC study using dried
newborn blood shows the presence of maternal HIV antibodies that were
transmitted to the newborn. This test allows the CDC to monitor HIV
seroprevalence of women giving birth. 46 Only about 30 percent of newborns
who test positive will actually become infected with HIV.4 7 Newborn HIV
testing is essentially indirect maternal HIV testing. As discussed below, this
42 Id. at 792.
43 See Cuckle, supra note 12 and accompanying text.
44 MDPH Policy Statement, supra note 25.
45 PerinatalHIV Testing, supra note 18, at 791.
46 See supra notes 24-27 and accompanying text; AIDS Testing Urged, supra note 40.
47

See supranote 20 and accompanying text.
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raises informed consent problems. Further, although the testing method may
be accurate for the maternal HIV antibody, its false positive rate has not been
established.
Currently, physicians are reluctant to treat newborns who merely show the
presence of their mother's HIV antibody because of the serious side effects of
anti-AIDS drugs. Several different tests are being developed which may
address this concern by determining the infection status of the infant. These
tests include culture, polymerase chain reaction, and detection of
48
infant-produced, HIV-specific antibodies of the IgA and/or IgM classes.
These tests may allow physicians to treat only those newborns actually infected
with HIV, rather than all newborns who have maternal HIV antibodies.
B. Informed Consent
Traditionally, if a physician treats a patient without informed consent, he has
committed the tort of assault and battery.49 Informed consent is distinct from
general consent in that it involves the:
duty of a physician to make reasonable disclosures to his or her patient
regarding the potential risks of the proposed treatment, expected
benefits, and alternative treatments. A physician who fails to inform
or alternative
his or her patient of the potential results of the treatment 50
methods of treatment may be held liable for negligence.
These concepts of consent typically relate to implications of invasive
procedures to the patient. A simple blood test traditionally does not involve
informed consent. However, "due to the early hysteria regarding AIDS...
special informed consent practices developed concerning HIV testing. Clearly
this represents an expansion of the legal 'informed consent' requirement." 51
Currently, there is a consensus among public health professionals that
informed consent should be obtained prior to HIV testing. 52 The National
Academy of Sciences' Institute of Medicine reported on January 15, 1991, that
routine HIV screening of newborns was not only unjustified because the tests
are inconclusive in newborns, 53 but also, "'[u]sing newborn HIV screening to
identify HIV-infected mothers would . . . mean that post-partum women
currently would be the only civilian, non-institutionalized adult population
not given the opportunity to consent to or refuse HIV testing, an outcome that

48

PerinatalHIV Testing, supra note 18, at 791 (citations omitted).

49 Salwa G. Spong, AIDS and the Health Care Provider: Burgeoning Legal Issues, 67
MICH. B.J. 610, 614 (1988) (citing Franklin v. Peabody, 288 N.W.2d 681 (Mich. 1930);
Banks v. Wittenberg, 266 N.W.2d 788 (Mich. App. 1978)).
50Id. (citations omitted).
51 Id.at 615-16.
52 Id. at 616.
53 Cimons, supra note 40, at A19 col. 1.
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The American Academy of Pediatrics Task Force

on Pediatric AIDS also recommends that "[t]esting in the perinatal period
should occur under specified polices which ensure retesting, education,
informed consent, counseling, and follow-up criteria." 55
Another compelling argument in favor of informed consent prior to HIV
testing is found in the Ryan White Comprehensive AIDS Resources Emergency
Act (CARE) which Congress enacted in 1990 to direct AIDS relief. 56 The specific
purpose of the CARE Act is to provide:
emergency assistance to localities that are disproportionately affected
by the Human Immunodeficiency Virus epidemic and to make
financial assistance available to States and other public or private
nonprofit entities to provide for the development, organization,
coordination and operation of more effective and cost efficient systems
for the delivery
of essential services to individuals and families with
5
HIV disease. '
There are three major entitlements in the CARE Act.58 To receive Title III
funds, certain restrictions apply. All Title III grants must provide pre-test and
post-test counseling. 59 The statute states:
300ff-61. Confidentiality and informed consent

(b) Informed consent
(1) In general
The Secretary may not make a grant under this part unless the
applicant for the grant agrees that, in testing an individual for HIV
disease, the applicant will test an individual only after obtaining from
the individual a statement, made in writing and signed by the
individual, declaring that the individual has undergone the counseling
described in section 300ff-62(a) of this title and that the decision of the

54 Id. citing Institute of Medicine Report (Jan. 15, 1992).
55 PerinatalHIV Testing, supra note 18, at 793.
56 42 U.S.C. § 300ff (Supp. 1111989-1992).
57

Raymond C. O'Brien, A Legislative Initiative: The Ryan White Comprehensive AIDS
Resources Emergency Act of 1990, 7 J. CONTEMp. HEALTH L. & POLICY 183, 188 (1991)
(quoting Pub. L. No. 101-381, § 2,104 Stat. 576).
58They include:
Title I-HIV Emergency Relief Grant Program (creating and amending
Title XXVI--HIV Health Care Services Program of the Public Health
Service Act) directed towards metropolitan areas;
Title ll--HIV Care Grants (amending Title XXVI) directed towards the
states; and
Title III--Early Intervention Services (amending Title XXVI) directed
towards the states and efforts to test, educate, and counsel.
O'Brien, supra note 57, at n.22.
59

1d. at 199. Seealso, 42 U.S.C.A. § 300ff-61(a) (Pub. L. No. 101-381, 104 Stat. 576, 609).
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individual
with respect to undergoing such testing is voluntarily
60
made.

Clearly Congress finds counseling and informed consent an important
aspect of any HIV testing program. 61 In contrast, the proposed Michigan Bill
mandating HIV testing does not require any counseling and informed consent
for newborn results. 62 Additionally, the MDPH staff state that adding HIV
testing to the newborn screening program would jeopardize continued CDC
63
funding of Michigan's maternal HIV seroprevalence survey.
C. Confidentiality in Newborn Screening
The United States Supreme Court has "recognized a 'zone of privacy,'
encompassed in the Constitution [that] protects against unwarranted
governmental intrusions into personal matters." 64 In Whalen v. Roe, 65 the Court
extended this right to an "individual['s] interest in avoiding disclosure of
personal matters."66 "Nevertheless, disclosures of private medical information
to doctors, to hospital personnel, to insurance companies, and to public health
agencies are often an essential part of modem medical practice even when the
67
disclosure may reflect unfavorably on the character of the patient."
Newborn screening programs in this country often retain data, including test
results, on all infants screened. (All Michigan newborn screening results have
been maintained in a computerized database since October 1,1987). One author
has warned,
[i]f mass screening programs collect and retain data about persons
screened, other persons may seek access to some of the data for a
variety of purposes, such as seeking compatible bone marrow or other
organ donors or attempting to locate biological parents (or offspring)

60 42 U.S.C. § 300ff-61(b)(1) (Supp. HI 1989-1992).
61 The state of Michigan and its municipalities are therefore obligated to use of
informed consent process by accepting funds under this Act. As of July 20, 1992, the
MDPH receives approximately $1,207,302 annually under Title 11of this Act. Further,
programs within the cities of Detroit and Grand Rapids combined receive
approximately $1,275,000 annually under Title Ill.
62 1992 M.H.B. 5863, supra note 35 and accompanying text at § 5133(14).
63 MDPHPolicy Statement, supra note 25.
64
Spong, supranote 49, at 616 (citing Roe v. Wade, 410 U.S. 113 (1973); Eisenstadt v.
Baird, 405 U.S. 438 (1972); Griswold v. Connecticut, 381 U.S. 479 (1965).
65429 U.S. 589 (1977).
66

1d. at 599 (footnote omitted). See also Spong, supra note 49, at 616.

67

Whalen, 429 U.S. at 602 (footnote omitted).
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Making such information available without a

68
court order may well expose screening programs to liability.

Concerns for confidentiality and resulting liability are particularly
important with HIV results due to the stigma associated with being designated
HIV positive. "Persons with AIDS or HIV infection have a very strong interest
in maintaining the confidentiality of their health status, particularly given the
close association of H1V infection with sexual practice and drug use, and the
ensuing social ostracism and discrimination potential that may accompany a
positive HIV test result. "69 Physicians routinely contact newborn screening
programs for the status of their patient's newborn screen. 70 Additional
procedures for safeguarding HIV data would be needed if the proposed
Michigan bill became law.
D. Newborn Screening Refusals
The MDPH staff are also concerned about how the addition of newborn HIV
testing would affect screening refusals. It is estimated that each year there are
only about ten families that refuse newborn screening. 71 That is extremely low
considering there are 150,000 Michigan births each year. If HIV testing is
mandated, it is expected that this number of refusals would significantly
increase. This is based on
experience that shows. . . when HIV testing is perceived to be forced
on an individual, or when testing is done without the proper consent,
people react negatively due to the stigma associated with HIV, concern
about how the test results will be used, lack of understanding about
the meaning of the test results,... 72
This increased refusal rate would not only impact HIV testing but also would
adversely affect the entire newborn screening program. 73

68
Legal Liability and Quality Assurance in Newborn Screening, AMERICAN BAR
FOUNDATION at 134 (Lori B. Andrews, ed. 1985) (citing Roger B. Dworkin, Legal Issues
Posed by Newborn Screening Program).
69

Spong, supra note 49, at 616.

70

1n Michigan there are approximately 20 such requests every day.

71

MDPH PolicyStatement, supranote 25. See Bayer, supranote 39 at 4 ("[V]ast majority
of [HIV] infected women who are hospitalized during childbirth choose not to be tested
when counseled about the importance of knowing their own HIV status.").
72

MDPH Policy Statement, supra note 25.

73 With increased refusals, some cases of currently screened disorders would be
missed. For example, a five percent refusal rate in Michigan would result in
approximately two missed cases each year of congenital hypothyroidism, a sporadic
disorder leading to severe mental retardation if untreated.
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V. CURRENT MICHIGAN LAW FOR PRENATAL HV TESTING
Since 1988, Michigan has mandated, under M.C.L.A. § 333.5123, that
pregnant women be offered prenatal testing for HIV (as well as for other
venereal diseases and hepatitis B). 74 The test samples are obtained on the
woman's initial prenatal visit. This law not only benefits the mother, but also
her baby. Many believe this is the best time to test for HIV so long as there is
counseling and informed consent. 75 This is also the best time to identify infants
exposed to hepatitis B and venereal disease. When HIV results are available
prenatally, the affected mother can be counseled and educated to prevent risk
behaviors and transmission (such as avoiding breast feeding, which may
transmit the virus).76 These benefits are not achievable using the newborn
77
screening method.
A potential drawback of M.C.L.A. § 333.5123 is that it allows too much
opportunity to opt out of the prenatal HIV test. The law states:
This subsection shall not apply if, in the professional opinion of the
physician or other person, the tests are medically inadvisable or the
woman does not consent to be tested.
This language creates a path of least resistance for health care providers to
avoid performing these prenatal tests. Although no statewide data are
available, anecdotal accounts indicate that this prenatal testing is not being
conducted comprehensively. Perhaps public health needs would be better
served if Michigan Bill 5863 proponents sought to strengthen prenatal HIV
testing legislation instead of mandating HIV testing of newborns.
VI. CONCLUSION
Only New Jersey and Michigan have introduced legislation concerning
non-anonymous HIV testing of newborns. The New Jersey Bill was rejected;

74 M.C.L.A. § 333.5123.
AIDS test for pregnant women
Sec. 5123. (1) A physician or an individual otherwise authorized by law
to provide medical treatment to a pregnant woman shall take or cause
to be taken, at the time of the woman's initial examination, test specimens
of the woman and shall submit the specimens to a clinical laboratory
approved by the department for the purpose of performing standard
venereal disease tests approved by the department, a test for MV or
antibody to IV, and a test for hepatitis B. This subsection shall not apply
if, in the professional opinion of the physician or other person, the tests are
medically inadvisable or the woman does not consent to be tested.
75 PerinatalHIV Testing supra note 16, at 792. See also, MDPH Policy Statemwnt, supra
note 25.
76 MDPH Policy Statenment, supra note 25.
77 Other benefits of prenatal testing for these conditions are the ability to prepare for
vaccination of the infant against hepatitis B immediately after birth and the ability to
treat syphilis during pregnancy, thus preventing congenital syphilis.
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Michigan House Bill 5863, as substituted, although overwhelmingly passed by
the Michigan House of Representatives, died at the close of the State's
1991-1992 legislative session, only to be introduced again in 1993 in a
substantially similar form.
The current consensus in the legal, scientific and public health community
is that mandating newborn screening for HIV does not meet goals of
identification and follow-up of HIV infected mothers or newborns. Testing
newborns without parental informed consent or counseling would, in effect,
result in the involuntary HIV screening of every woman giving birth. If forced
to include non-anonymous HIV tests, state newborn screening programs
would be adversely affected due to an increased number of refusals and
inefficiencies created by the need to maintain stricter confidentiality of test
results.
Considering issues of informed consent, confidentiality, possible newborn
screening refusals, and the potential for identifying HIV-exposed neonates
through prenatal testing, the addition of non-anonymous HIV testing to
routine newborn screening appears to be neither efficient nor ethically
defensible. Enhancing prenatal HIV testing with informed consent is a more
preferable course for legislatures to follow.

